2014Unpublished venueRequires access

Toxicokinetics and Toxicogenetics

Markus R. Meyer, Hans H. Maurer

Open publisher page 3 citations

Abstract

Toxicokinetics deals with what the body does with a compound given at a non-toxic dose or a relatively high dose. Toxicogenetics considers the effect of inherited differences in the metabolism of xenobiotics and their response, while toxicogenomics refers to the general study of all of the many different genes that determine xenobiotic behaviour. The fate of a xenobiotic in the human body can be described by the so-called Liberation, Absorption, Distribution, Metabolism, and Excretion (LADME) scheme. The parameters that characterise the LADME process are bioavailability, volume of distribution and clearance. Compared to classic pharmacokinetics, toxicokinetics may often vary due to remarkable variations in plasma concentration of the xenobiotics, long-time exposure to them leading to, for example, damage of liver or kidneys. Xenobiotics such as therapeutic drugs, drugs of abuse and other toxic compounds can be chemically modified by various metabolising enzymes.

About this research paper

What this paper is about

Toxicokinetics deals with what the body does with a compound given at a non-toxic dose or a relatively high dose. Toxicogenetics considers the effect of inherited differences in the metabolism of xenobiotics and their response, while toxicogenomics refers to the general study of all of the many different genes that determine xenobiotic behaviour. The fate of a xenobiotic in the human body can be described by the so-called Liberation, Absorption, Distribution, Metabolism, and Excretion (LADME) scheme. The parameters that characterise the LADME process are bioavailability, volume of distribution and clearance. Compared to classic pharmacokinetics, toxicokinetics may often vary due to remarkable variations in plasma concentration of the xenobiotics, long-time exposure to them leading to, for example, damage of liver or kidneys. Xenobiotics such as therapeutic drugs, drugs of abuse and other toxic compounds can be chemically modified by various metabolising enzymes.

Why it matters

OpenAlex reports 3 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Toxicokinetics deals with what the body does with a compound given at a non-toxic dose or a relatively high dose. Toxicogenetics considers the effect of inherited differences in the metabolism of xenobiotics and their response, while toxicogenomics refers to the general study of all of the many different genes that determine xenobiotic behaviour. The fate of a xenobiotic in the human body can be described by the so-called Liberation, Absorption, Distribution, Metabolism, and Excretion (LADME) scheme. The parameters that characterise the LADME process are bioavailability, volume of distribution and clearance. Compared to classic pharmacokinetics, toxicokinetics may often vary due to remarkable variations in plasma concentration of the xenobiotics, long-time exposure to them leading to, for example, damage of liver or kidneys. Xenobiotics such as therapeutic drugs, drugs of abuse and other toxic compounds can be chemically modified by various metabolising enzymes.

Key concepts: Xenobiotic, Toxicokinetics, Bioavailability, Pharmacokinetics, Chemistry, Drug metabolism, Volume of distribution, Toxicogenomics

Related papers

Back to paper searchBrowse research topicsOriginal source
Toxicokinetics and Toxicogenetics — Research Paper | ScholarLens